Carregant...
Abc1p Is a Multidrug Efflux Transporter That Tips the Balance in Favor of Innate Azole Resistance in Candida krusei
Most Candida krusei strains are innately resistant to fluconazole (FLC) and can cause breakthrough candidemia in immunocompromised individuals receiving long-term prophylactic FLC treatment. Although the azole drug target, Erg11p, of C. krusei has a relatively low affinity for FLC, drug efflux pumps...
Guardat en:
Autors principals: | , , , , , , , |
---|---|
Format: | Artigo |
Idioma: | Inglês |
Publicat: |
American Society for Microbiology (ASM)
2009
|
Matèries: | |
Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2630665/ https://ncbi.nlm.nih.gov/pubmed/19015352 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01095-08 |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|